Anti-epidermal growth factor vaccine antibodies increase the antitumor activity of kinase inhibitors in ALK and RET rearranged lung cancer cells

Advanced NSCLC patients harboring EML4-ALK and CCDC6-RET rearrangements derive benefit from treatment with ALK and RET TKIs but not immune checkpoint inhibitors. New immunotherapeutic approaches, such as immunization against growth factors, can be of particular interest for combination treatment in...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Transl Oncol
Main Authors: Codony-Servat, Jordi, García-Roman, Silvia, Molina-Vila, Miguel Ángel, Bertran-Alamillo, Jordi, Viteri, Santiago, d'Hondt, Erik, Rosell, Rafael
Formato: Artigo
Idioma:Inglês
Publicado em: Neoplasia Press 2020
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7591385/
https://ncbi.nlm.nih.gov/pubmed/33129112
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tranon.2020.100887
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados